Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes

被引:12
作者
Li, Yiquan [1 ,2 ]
Zhu, Yilong [2 ,3 ]
Chen, Shuang [1 ,2 ]
Li, Wenjie [2 ,3 ]
Yin, Xunzhe [2 ,3 ]
Li, Shanzhi [2 ]
Xiao, Pengpeng [1 ,2 ]
Han, Jicheng [1 ,2 ]
Li, Xiao [2 ,3 ,4 ]
Sun, Lili [2 ,5 ]
Jin, Ningyi [1 ,2 ,3 ,4 ]
机构
[1] Yanbian Univ, Med Coll, Yanji, Peoples R China
[2] Acad Mil Med Sci, Inst Mil Vet Med, Changchun, Jilin, Peoples R China
[3] Changchun Univ Tradit Chinese Med, Changchun, Jilin, Peoples R China
[4] Wenzhou Univ Town, Inst Virol, Wenzhou, Peoples R China
[5] Tumor Hosp Jilin Prov, Dept Head & Neck Surg, Changchun, Jilin, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2017年 / 7卷
关键词
attenuated vaccinia virus vector; homologous recombination; vaccinia Tiantan strain virus; virulence; immunogenicity; TAN STRAIN; HOST-RANGE; INTRANASAL VACCINATION; IMMUNE-RESPONSES; IFN-GAMMA; IN-VIVO; VIRULENCE; RECOMBINANT; PROTEIN; IMMUNOGENICITY;
D O I
10.3389/fcimb.2017.00462
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An attenuated vaccinia virus-MVTTEAB-was constructed by deletion of non-essential gene segments related to the immunomodulatory and virulence functions of the vaccinia virus Tiantan strain (VVTT). The shuttle plasmids pTC-EGFP, pTE-EGFP, pTA35-EGFP, pTB-EGFP, and pTA66-EGFP were constructed and combined with the early and late strong promoter pE/L and EGFP as an exogenous selectable marker. Then, through the homologous recombination technology and Cre/loxP system, the following gene fragments were gradually knocked out one by one: TC7L-TK2L, TE3L, TA35R, TB13R, and TA66R. Ultimately, the five-segment-deleted attenuated strain MVTTEAB was obtained. Knockout of these segments and genetic stability of MVTTEAB were confirmed, and it was also shown that knockout of these segments did not affect the replication ability of the virus. Further, a series of in vivo and in vitro experiments demonstrated that the virulence of MVTTEAB was attenuated significantly, but at same time, high immunogenicity was maintained. These results indicate that MVTTEAB has potential for clinical use as a safe viral vector or vaccine with good attenuation and immunogenicity.
引用
收藏
页数:13
相关论文
共 39 条
  • [1] Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
    Adelfinger, Marion
    Gentschev, Ivaylo
    de Guibert, Julio Grimm
    Weibel, Stephanie
    Langbein-Laugwitz, Johanna
    Haertl, Barbara
    Escobar, Hugo Murua
    Nolte, Ingo
    Chen, Nanhai G.
    Aguilar, Richard J.
    Yu, Yong A.
    Zhang, Qian
    Frentzen, Alexa
    Szalay, Aladar A.
    [J]. PLOS ONE, 2014, 9 (08):
  • [2] CYTOKINE RECEPTORS ENCODED BY POXVIRUSES - A LESSON IN CYTOKINE BIOLOGY
    ALCAMI, A
    SMITH, GL
    [J]. IMMUNOLOGY TODAY, 1995, 16 (10): : 474 - 478
  • [3] Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model
    Brandt, TA
    Jacobs, BL
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (02) : 850 - 856
  • [4] Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification
    Brennan, Greg
    Kitzman, Jacob O.
    Shendure, Jay
    Geballe, Adam P.
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (19) : 9986 - 9997
  • [5] DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE
    BULLER, RML
    SMITH, GL
    CREMER, K
    NOTKINS, AL
    MOSS, B
    [J]. NATURE, 1985, 317 (6040) : 813 - 815
  • [6] Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
    Cottingham, Matthew G.
    Andersen, Rikke F.
    Spencer, Alexandra J.
    Saurya, Saroj
    Furze, Julie
    Hill, Adrian V. S.
    Gilbert, Sarah C.
    [J]. PLOS ONE, 2008, 3 (02):
  • [7] Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion
    Embry, Addie
    Meng, Xiangzhi
    Cantwell, Angelene
    Dube, Peter H.
    Xiang, Yan
    [J]. VACCINE, 2011, 29 (33) : 5331 - 5339
  • [8] Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence
    Fahy, Aodhnait S.
    Clark, Richard H.
    Glyde, Emily F.
    Smith, Geoffrey L.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 2377 - 2387
  • [9] Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain
    Fang, Q
    Yang, L
    Zhu, WJ
    Liu, L
    Wang, HB
    Yu, WB
    Xiao, GF
    Tien, P
    Zhang, LQ
    Chen, ZW
    [J]. VIROLOGY, 2005, 335 (02) : 242 - 251
  • [10] Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence
    Ferguson, Brian J.
    Benfield, Camilla T. O.
    Ren, Hongwei
    Lee, Vivian H.
    Frazer, Gordon L.
    Strnadova, Pavia
    Sumner, Rebecca P.
    Smith, Geoffrey L.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 2070 - 2081